Houston, TX, United States of America

Susan M North


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Susan M North

Introduction

Susan M North is a prominent inventor based in Houston, TX (US). She has made significant contributions to the field of medical research, particularly in the identification of metastatic human tumors. Her work has implications for both detection and prevention of tumor lesions, showcasing her dedication to advancing healthcare.

Latest Patents

Susan M North holds a patent for "Methods and compositions for the identification of metastatic human." This patent discloses monoclonal antibodies that react specifically with human tumor cells, especially metastatic ones, while not affecting normal human tissues. The antibodies are prepared against a 580 kilodalton glycoprotein antigen, designated gp580, which is isolated from either rat or human tumor cells. The patent also outlines methods for isolating this glycoprotein antigen and techniques for utilizing these antibodies in the detection and prevention of human tumor lesions. She has 1 patent to her name.

Career Highlights

Susan M North is affiliated with the University of Texas System, where she continues her research and innovation in the medical field. Her work has garnered attention for its potential to improve cancer diagnostics and treatment options.

Collaborations

Some of her notable coworkers include Garth L Nicolson and Peter A Steck, who have collaborated with her on various research projects.

Conclusion

Susan M North's innovative work in the identification of metastatic human tumors exemplifies her commitment to advancing medical science. Her contributions are vital in the ongoing fight against cancer, and her patent reflects her significant impact in this critical area of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…